Breast Disease
An International Journal
ISSN: 0888-6008
Volume 33; 4 issues
Institutional subscription (print and online) for 2011: €448 / US$575 (including postage and handling)
Click on the subscribe button for more options, including personal subscription prices.
Status Report: Last issue (volume 31:2) online on 2 March 2011
Next issue (volume 31:3) scheduled for June 2011

Aims and Scope
Editorial Board
Submission of Manuscripts

Download flyer for this journal

Jeffrey E. Green, MD
Bethesda, MD, USA

Founding Editor
Edison T. Liu
Executive Director, Genome Institute of Singapore

Editorial Board
W.G. Cance J. Reese-Coulbourne
C.V. Clevenger B. Rimer
C.S. Hultman A. Seidman
S. Lipkowitz W.-Z. Wei
D.M. Lopez Y. Yarden
K.D. Miller D. Yee
E. Pisano 

Submission of Manuscripts 
See instructions to authors.
Aims and Scope 
The recent expansion of work in the field of breast cancer inevitably will hasten discoveries that will have impact on patient outcome. The breadth of this research that spans basic science, clinical medicine, epidemiology, and public policy poses difficulties for investigators. Not only is it necessary to be facile in comprehending ideas from many disciplines, but also important to understand the public implications of these discoveries.

Breast Disease publishes review issues devoted to an in-depth analysis of the scientific and public implications of recent research on a specific problem in breast cancer. Thus, the reviews will not only discuss recent discoveries but will also reflect on their impact in breast cancer research or clinical management.

From 2009 onward, Breast Disease also started publishing unsollicited peer-reviewed articles. The topics can cover basic cellular and molecular biology, epidemiology, genetics, clinical research, imaging, and social and legal issues.

The editorial team believes that Breast Disease will be a timely and important addition to the information needs of scientists, clinicians and policy makers.

IOS Press
Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
Tel.: +31 20 688 3355, Fax: +31 20 687 0019